(NASDAQ: AADI) Aadi Bioscience's forecast annual revenue growth rate of 32.48% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Aadi Bioscience's revenue in 2024 is $24,354,000.On average, 3 Wall Street analysts forecast AADI's revenue for 2024 to be $682,606,899, with the lowest AADI revenue forecast at $670,329,797, and the highest AADI revenue forecast at $701,268,095. On average, 2 Wall Street analysts forecast AADI's revenue for 2025 to be $832,142,007, with the lowest AADI revenue forecast at $748,412,168, and the highest AADI revenue forecast at $915,871,847.
In 2026, AADI is forecast to generate $1,477,917,599 in revenue, with the lowest revenue forecast at $1,355,392,116 and the highest revenue forecast at $1,600,443,082.